Interleukin-6 Receptor Antagonist [EPC]

102559 reported adverse events

Drugs of this class: SARILUMAB TOCILIZUMAB

These side effects are most commonly reported by patients taking drugs of the Interleukin-6 Receptor Antagonist [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 33274
1 RHEUMATOID ARTHRITIS 19968
2 PAIN 17819
3 OFF LABEL USE 15136
4 ARTHRALGIA 14994
5 JOINT SWELLING 13564
6 FATIGUE 12367
7 DRUG INTOLERANCE 10983
8 RASH 10946
9 CONTRAINDICATED PRODUCT ADMINISTERED 10193
See all common reactions for Interleukin-6 Receptor Antagonist [EPC]

Drugs of the Interleukin-6 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 283 0.9279
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3778 0.9023
2 DISABILITY ASSESSMENT SCALE SCORE INCREASED 244 0.8809
3 SWOLLEN JOINT COUNT INCREASED 1088 0.8533
4 RHEUMATOID FACTOR POSITIVE 3027 0.8157
5 PEMPHIGUS 6574 0.7827
6 RHEUMATIC FEVER 1329 0.7827
7 DEEP VEIN THROMBOSIS POSTOPERATIVE 413 0.6793
8 DUODENAL ULCER PERFORATION 2591 0.6638
9 GRANULOMA SKIN 469 0.6469
See all enriched reactions for Interleukin-6 Receptor Antagonist [EPC]